Calvary Central Districts Hospital joins CTA
Cancer Trials Australia is pleased to announce the addition of our 26th major healthcare provider member, Calvary Central Districts Hospital, located in South Australia. This partnership builds on Calvary's [...]
CTA to support VCCC Investigator Initiated Trial Program
Cancer Trials Australia (CTA) is pleased to announce execution of a Services Agreement with the VCCC to provide Site Management Services for the VCCC’s Investigator Initiated Trial Program. Professor [...]
2017 Cancer Trials Australia Annual Report
I am pleased to share the 2017 Cancer Trials Australia Annual Report. Download the 2017 Annual Report Here. 2017 saw expansion of CTA membership and significant growth in CTA services for [...]
CTA Celebrates 1,000 Commercially Sponsored Clinical Trials
Cancer Trials Australia celebrates their support of 1,000 commercially sponsored clinical trials and the recruitment of 8,000 patients, in conjunction with International Clinical Trials Day on May 21st, 2018 Since [...]
Fast, Quality Clinical Trials for Less: Let Melbourne, Australia be Your Partner
Cancer Trials Australia's CEO, Dr Kurt Lackovic, was recently invited to speak at an international webinar showcasing Melbourne as a premier location for the conduct of Phase 1 clinical trials. Aimed primarily at international [...]
Epworth HealthCare Joins Cancer Trials Australia
More patients will have access to potentially life-saving cancer therapies as a result of Epworth joining forces with Cancer Trials Australia. With the addition of Epworth, CTA now has [...]
2016 Cancer Trials Australia Annual Report
I am pleased to share the Cancer Trials Australia 2016 Annual Report. Download the 2016 Annual Report Here. 2016 saw growth in CTA membership and corresponding CTA service activity. CTA welcomed [...]
Linear Clinical Research Joins CTA Member Network
Cancer Trials Australia (CTA) is pleased to announce that Linear Clinical Research has signed a Members Agreement to join the CTA Member Network The CTA network now includes 24 [...]
Successful Cancer Council Victoria Grant Announcement
Cancer Trials Australia (CTA) is proud to be part of the successful Cancer Council Victoria (CCV) grant application for the establishment of a cancer clinical trials network across seven [...]
Cancer Trials Australia’s New Chief Executive Officer
Chairman of the Board, Professor Andrew Scott, with great pleasure advised that the next Chief Executive Officer of Cancer Trials Australia (CTA) will be Dr Kurt Lackovic. Professor Scott said [...]
GV Health and Lyell McEwin Hospital Join CTA
Cancer Trials Australia (CTA) announced today that the Shepparton Hospital, through Goulburn Valley Health, and Northern Adelaide Cancer Centre Clinical Trials Unit, operating as the Lyell McEwin Hospital, have [...]
BeiGene AACR Results
A new RAF-targeted therapeutic has shown early promise against tumours in Phase 1 trials. Doctors Jayesh Desai (1), Ben Solomon (2) and Hui Gan (3)have established a highly successful collaboration [...]
South West Healthcare Signs on with CTA
Cancer Trials Australia (CTA) announced today that South West Healthcare had signed an agreement to join CTA. "Southwest Healthcare located at Warrnambool in Victoria services a large population over South [...]
New Chairperson for CTA Board
The Board of Directors of Cancer Trials Australia (CTA) today announced the appointment of Professor Andrew Scott as Chairperson.This appointment was made by the Board following the resignation of Professor [...]